Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
OPERATING ACTIVITIES
Net loss	$ (66,052,264)	$ (53,163,348)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	204,694	262,140
Loss on extinguishment of debt	1,025,402
Non-cash interest expense	1,655,340	893,886
Stock-based compensation	7,710,804	4,887,287
Change in fair value of unsecured convertible promissory note	882,903
Change in fair value of warrant liability	(465,780)	452,146
Gain on settlement of lease termination obligation		(552,340)
Loss on equity method investment	48,730	46,340
Changes in operating assets and liabilities:
Prepaid expenses and other current assets	(3,092,811)	(1,729,944)
Other assets		298,523
Operating lease liability	(42,854)	(150,346)
Accounts payable	1,295,136	(198,469)
Accrued expenses	156,141	(5,299,163)
Net cash used in operating activities	(56,674,559)	(54,253,288)
FINANCING ACTIVITIES
Proceeds from the sale of common stock, net of issuance costs	62,307,307	46,301,841
Proceeds from debt	10,000,000	10,000,000
Payment of debt issuance costs		(8,032)
Proceeds from exercise of common stock warrants	188,100	3,593,380
Proceeds from exercise of stock options	17,750
Payments of finance lease obligations	(26,464)	(29,778)
Repayment of stockholder notes		(3,612,500)
Repayment of debt	(12,292,646)	(50,285)
Payment of financing costs	(600,000)
Net cash provided by financing activities	59,594,047	56,194,626
Net increase in cash and cash equivalents	2,919,488	1,941,338
Cash and cash equivalents at beginning of year	14,477,324	12,535,986
Cash and cash equivalents at end of year	17,396,812	14,477,324
Supplemental disclosure of cash flow information
Cash paid for interest	1,556,691	$ 46,239
Supplemental schedule of non-cash financing activities:
Deferred offering costs amortization	$ 42,575